よむ、つかう、まなぶ。
03資料1-1森野委員提出資料（高齢者に対するインフルエンザワクチンファクトシート） (36 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64997.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第32回 10／22）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
3. 引用文献
1.
Ison MG, Lee N. Influenza. In: Goldman L, ed. Goldman-Cecil Medicine (Twenty Seventh
Edition): Elsevier; 2023: 332, 2198-203.e1.
2.
Nayak JL TJ. Chapter 172 - Influenza Viruses, Including Avian Influenza and Sweine
Influenza.
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 10 ed:
Elsevier Inc; 2026: 2126-51.e8.
3.
Paules C, Subbarao K. Influenza. Lancet 2017; 390(10095): 697-708.
4.
Uyeki TM. Influenza. Ann Intern Med 2021; 174(11): Itc161-itc76.
5.
Conrad A, Valour F, Vanhems P. Burden of influenza in the elderly: a narrative review. Curr
Opin Infect Dis 2023; 36(4): 296-302.
6.
Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza
illness: systematic review and meta-analysis. BMJ 2013; 347: f5061.
7.
Gozalo PL, Pop-Vicas A, Feng Z, Gravenstein S, Mor V. Effect of influenza on functional decline.
J Am Geriatr Soc 2012; 60(7): 1260-7.
8.
Andrew MK, Gilca V, Waite N, Pereira JA. EXamining the knowledge, Attitudes and
experiences of Canadian seniors Towards influenza (the EXACT survey). BMC Geriatr 2019; 19(1): 178.
9.
Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza
transmission in households: a cluster randomized trial. Ann Intern Med 2009; 151(7): 437-46.
10.
Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a
meta-analysis of randomised controlled trials. Lancet 2015; 385(9979): 1729-37.
11.
Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical Practice Guidelines by the Infectious
Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional
Outbreak Management of Seasonal Influenza. Clin Infect Dis 2019; 68(6): e1-e47.
12.
Gao Y, Guyatt G, Uyeki TM, et al. Antivirals for treatment of severe influenza: a systematic
review and network meta-analysis of randomised controlled trials. Lancet 2024; 404(10454): 753-63.
13.
World Health Organization. Clinical practice guidelines for influenza. 2024/09/12 2024.
https://www.who.int/publications/i/item/9789240097759
14.
Wolpert MF. Influenza. In: Ferri FF, ed. Ferri's Clinical Advisor 2025: Elsevier; 2025: 645.e2-.e7.
15.
Cavallazzi R, Ramirez JA. Influenza and Viral Pneumonia. Infect Dis Clin North Am 2024;
38(1): 183-212.
16.
Howley PM. Chapter 14 - Orthomyxoviridae: The Viruses and Their Replication, Chapter 15 -
Orthomyxoviruses.
Fields Virology 7th edition: Emerging viruses: a Wolters Kluwer business; 2021:
596-705.
17.
Karakus U, Mena I, Kottur J, et al. H19 influenza A virus exhibits species-specific MHC class II
receptor usage. Cell Host Microbe 2024; 32(7): 1089-102.e10.
18.
Fereidouni S, Starick E, Karamendin K, et al. Genetic characterization of a new candidate
hemagglutinin subtype of influenza A viruses. Emerg Microbes Infect 2023; 12(2): 2225645.
19.
Barr IG, Subbarao K. Implications of the apparent extinction of B/Yamagata-lineage human
36
1.
Ison MG, Lee N. Influenza. In: Goldman L, ed. Goldman-Cecil Medicine (Twenty Seventh
Edition): Elsevier; 2023: 332, 2198-203.e1.
2.
Nayak JL TJ. Chapter 172 - Influenza Viruses, Including Avian Influenza and Sweine
Influenza.
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 10 ed:
Elsevier Inc; 2026: 2126-51.e8.
3.
Paules C, Subbarao K. Influenza. Lancet 2017; 390(10095): 697-708.
4.
Uyeki TM. Influenza. Ann Intern Med 2021; 174(11): Itc161-itc76.
5.
Conrad A, Valour F, Vanhems P. Burden of influenza in the elderly: a narrative review. Curr
Opin Infect Dis 2023; 36(4): 296-302.
6.
Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza
illness: systematic review and meta-analysis. BMJ 2013; 347: f5061.
7.
Gozalo PL, Pop-Vicas A, Feng Z, Gravenstein S, Mor V. Effect of influenza on functional decline.
J Am Geriatr Soc 2012; 60(7): 1260-7.
8.
Andrew MK, Gilca V, Waite N, Pereira JA. EXamining the knowledge, Attitudes and
experiences of Canadian seniors Towards influenza (the EXACT survey). BMC Geriatr 2019; 19(1): 178.
9.
Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza
transmission in households: a cluster randomized trial. Ann Intern Med 2009; 151(7): 437-46.
10.
Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a
meta-analysis of randomised controlled trials. Lancet 2015; 385(9979): 1729-37.
11.
Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical Practice Guidelines by the Infectious
Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional
Outbreak Management of Seasonal Influenza. Clin Infect Dis 2019; 68(6): e1-e47.
12.
Gao Y, Guyatt G, Uyeki TM, et al. Antivirals for treatment of severe influenza: a systematic
review and network meta-analysis of randomised controlled trials. Lancet 2024; 404(10454): 753-63.
13.
World Health Organization. Clinical practice guidelines for influenza. 2024/09/12 2024.
https://www.who.int/publications/i/item/9789240097759
14.
Wolpert MF. Influenza. In: Ferri FF, ed. Ferri's Clinical Advisor 2025: Elsevier; 2025: 645.e2-.e7.
15.
Cavallazzi R, Ramirez JA. Influenza and Viral Pneumonia. Infect Dis Clin North Am 2024;
38(1): 183-212.
16.
Howley PM. Chapter 14 - Orthomyxoviridae: The Viruses and Their Replication, Chapter 15 -
Orthomyxoviruses.
Fields Virology 7th edition: Emerging viruses: a Wolters Kluwer business; 2021:
596-705.
17.
Karakus U, Mena I, Kottur J, et al. H19 influenza A virus exhibits species-specific MHC class II
receptor usage. Cell Host Microbe 2024; 32(7): 1089-102.e10.
18.
Fereidouni S, Starick E, Karamendin K, et al. Genetic characterization of a new candidate
hemagglutinin subtype of influenza A viruses. Emerg Microbes Infect 2023; 12(2): 2225645.
19.
Barr IG, Subbarao K. Implications of the apparent extinction of B/Yamagata-lineage human
36